OpenEvidence's platform is freely available to all physicians, leading to widespread organic adoption and strategic partnerships with publishers like the New England Journal of Medicine.

OpenEvidence prioritizes the brand and mission of the New England Journal of Medicine, which is a nonprofit organization focused on maintaining the integrity of medical knowledge rather than pursuing commercial contracts.

By making OpenEvidence freely available, we enabled widespread adoption among U.S. doctors, with 10-20% starting to use it overnight to access new medical studies and improve diagnoses.

The rapid adoption of OpenEvidence, with over 100,000 physicians using it in the U.S. alone, demonstrates that doctors are consumers who will embrace effective tools that enhance their practice.

OpenEvidence allows doctors to drill down to the underlying sources of information, fostering a symbiotic relationship with medical publishers by driving traffic to their journals.

The use of OpenEvidence has already saved lives by helping doctors make better clinical decisions based on accurate medical information.

In an industry where organizations move slowly, 10-20% of all U.S. doctors began using OpenEvidence overnight to find information in new medical studies and improve diagnoses.

Open Evidence is a medical search platform that has grown to support over 25% of US practicing physicians as monthly active users, with many using it daily for critical information.

Open Evidence has the opportunity to aggregate medical knowledge from millions of physicians worldwide, encoding and improving care by leveraging distributed clinical wisdom.